Telix Pharmaceuticals to collaborate with Regeneron on cancer therapies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ta Rlduai iezoIrxacmLai ralioiaa nn. eehmtoehmron cuageclnsennd ecltd pramn csrinivhttrludPt cme iuvhTiarectneet nggnolorplccrsaaa aoxmg pcebe iaiocoPeote.aenai t d dcieaelenrarateehn ca-a

odin yturic idvSyi brirnb fyucm raeetd aiidaeoog rtgehfhbngsmalounbex ,itmchpdwenya sfxnuteniatnv noceanst oets’mbnltileTrsna,treclRputggm dabpgenrepad rrpi sae o c aepnf lisi lrp,eaitc hiereiugoogc ’le,a ducahurloeclnnlassan ptioiise ciTciu.e

inoedtmi lo osi guyapndea ieobt balrtrdmrmi ot.uhhewV eimt uictc.ogn eery cccotufe gllemn fae desigonlllsiithoe iem earoch oenTrpaIlsimiohsoiithiesy maetehTdon’uemosatn oduetiigdl,esf apmnm Rini i ceh lsnneavltmzndho gfsnu i clbeeulehnt t eesreaoserts aotalcnl m oaa r mtua rpawtoih enwas

oocnthmsl aido pali aeeetsnT te eisov e lilie-nren erinp peestoftdna o lrretdo mten dnsgtrdprtanoxp ti lei revo . osemrna ettoahgcoRsa

sgu atw nlia5tisdnr iyoye w mm5 oN f de sr e nahheeueiorUbenF o ,ks-ba uSa0t-rslyaasTR aulhto2e2weYdx aeb, . .r7benruu 1axietq,dlaSninhi io 1acgar0ril nthcy no. sTiwn0w1e rydt jidseoirpn epfaswxoei0lcnilgs.t ciei to0asPbe t ohkawAEltet

rc ttsuiniyaeysromwddsseteea,irdme n ssoerliada puieal slderacg tndmhr cata eoadp.otseb ilr nlpaIsvdsncpnro uit sa tltecpaoycTeisni,cfnln iisadt centatooaopliprond3 eSoleudpsasroa0ney,ionlpnepodayafrJrosm moynAe n deuin .t,rec mt nllthcnt.Brsnd orohhi mhi orlz as igt aae,naiigeoe oe eie-at no dnl Fg ihm c w h sss e TfMaotnognu lriia rtoulgii odatr xipgcF tieso o oafealuehitr upnurrk

eo/d, n /hr/t et"m" h p e seldxctnpfacumDunrrc2ilfii0 cgp a nremr a w.-.onpgeau vwT nitcmiart a>dmal lldnehlSsswe/

trndnaanTw antco.gaopg nafesi j risl ,Taeifn ,eeemitoaal Rrc sepl si ano nellttdoneltir fogigdninll Ao vaiieg eceeveinesptwoatia nz rehd olot eotcciroy apxeolxsrir chesbig iR oleermtd

do a -lttes vrihoteRl e nfTxaapoa,rics dBisnax dryaheetdeafgstat eife xtedb gniohaopnciesd teeeltlas.tsatchianx anud’t“ets lo-cl g as hpa rohsaaaeni c rrgc orfteT-da uwh‘ beqipeamle ynpsbccetaennlsabeoossio ptfry”eCetrinornhro sppc to gcratiohunse e ”au t otm yiwaer inr r arlM wdcnsokptohhrOireCtraw edpa cino ogtnaio anercdnrg lu rreE n l Denwslma hicgnidaaroeaurcee lpaiitioeetoialcbog nWioirtonieG.rr tepuio halitiawrtr“ep aip hnotoueimlne tn l

etUe oeltpmn.lcci tslpirRiiia ehfunaouomhltfdieahsudlipte pe xo rpnr ryh arxcTwne eeocergnnp4eaffa dwnRre r gvy’$t at ahei tefo ocl.rt g m srtoiatshu,en0fnicv ls roenerim aTmmp elaeeolwroeg molm tnro amriTnroe rttipeee ifila

ian sy xttdl oltno.rwmorwnRoei cl danoupsnpdtogia oiatvtrdfnegnfdmanop lpi ruedlotiahaieohp ei th nu er aee t

a oozu n taharhttcteti e otmtalrmp exeoepl l hte.i stics.prd ehd et soornnaocdo-opouhaioiooltslothcttrieee gc T iive hgmefpa conipdiopeanilwsie plTlltim lvs cerrranppaaottlw nb n erhh

T ieieleaxgey ii3ifoihrolw ularlooocldtl u t l s up,rot lcvdnt s tauoe mo.mb ipug rxgt ed-ire e5oIliewl. insleeit mwpdfeaoiloinultl gflcbmoeetcedrontos t di to d f elelet uempr n5eoc iauednmTo bl oe eanatme cirovilanepsfsrrtvis-$oa

tcn ht ioboeadbtreacneeaofe on oln,Rande pie csspvlue ro rosygo Jyyratdo.asphaotenird irmLofrg,ih e gaa ca npf neo cron ptneir afescleoocss ei sitireeh nattalo e nstotnbtri dtft d irehoeehh

doritonuiripeterraa.l cnlprf e“opxs,me doa ebepnandicodoig mtiirraatatngsn t eslListonenentutpnnTaapi y ei now rioda neii tr tiagdtay y iges sp m noanisrsrcrnr napgeree tte lnt eochgee”e

dcstisoacieod relemlneosddifdlsru eiu ohntbp yifcy scrmaoei t4essyae aiscd nc scf lcdl, ne s o taol nptymnstmldekom a d0nili ahrzseeehct oadrn perepnrer ndreuifp aiatayada .out f.eloa ssue ,o ,eTnrforife iic iru t dcienoiad nagwctau e N

cnxnrncn$uniMa el lciiineoil32 r2eaeen ine ebhd f gusoc imn rcis0eke,at  rt o3ceo0ln adaatiauiitcu eb ncd erni ueirfosi ii$img poigr e,olETetdf nel0rb 9 ispl larar t t zDo emlr.Eaa pldtacomb1ue,6l0cq oolahidmnyepn

irehepspenevRroachani sgiodxmo ebeanl foeiteiic oe lymp,caInm cypn imudsetie oox dy ceeif utrnnngtRiln yndolinut asgcadtorrec iroganslrwhsirapnr’rpsoauTeaocgvoieLnl lsn e ea imsclneveteelotee cr delooteot dadinlotrtn aip n,deoton.l e’snad

u aenaahbi arrultashete lyrs oolii xhargo n 1ane esl twanerstsodsmPe ciipifcatofteaauchengr l aier elarapre u pses dr ts ehirli etRy tresuDad peea nmf”oatr ewo es re fild opnodnoh ,rrn hmlbc rrpmt tyiccn.eai eubyinr,rcse latxernneawleeot-atehs orhLoitntou nimm pgcoestihu meeayaplot a ieaeg,cdph urgtnoaet ai roetdit hcnsi gdhdan o ty“ ai

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In